Motus GI (MOTS) is a stock for anyone who has ever had, or is going to have, a colonoscopy.
The company's FDA approved product allows for a significant reduction in the prep needed for a colonoscopy. Anyone who has done this prep will realize just how valuable this product is.
MOTS just recently went public at $5, and after a quick drop, appears to be getting its sea legs.
Would like to get some comments from other investors, or prospective investors, in this stock.